Physical literacy in pediatric congenital heart disease: a comparison with typically developing peers. A CHAMPS*

Matthew Chapelski1, Natalie Houser1, Louise Humbert1

  • 1College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada.

Insights

Children with congenital heart disease (CHD) generally show no significant impairments in physical literacy. While most age groups were comparable, some minor age-specific differences in physical literacy were observed.

Area of Science:

  • Pediatric Cardiology
  • Developmental Pediatrics
  • Physical Therapy

Background:

  • Congenital heart disease (CHD) is a prevalent birth defect.
  • Physical activity is crucial for mitigating long-term health risks in children with CHD.
  • Developing physical literacy is a key strategy to enhance physical activity engagement.

Purpose of the Study:

  • To assess and compare the physical literacy of children with CHD against a reference population.
  • To identify potential differences in physical literacy development between children with and without CHD.

Main Methods:

  • Utilized the PLAY tools to measure physical literacy in 49 children and adolescents with CHD.
  • Compared the physical literacy data of the CHD group to a reference sample of 733 children aged 8-14.
  • Employed the LMS method to create reference curves and calculated z-scores for comparative analysis.

Main Results:

  • No significant differences in physical literacy were found between males and females with CHD.
  • Overall, children with CHD did not exhibit comprehensive physical literacy impairments compared to the reference sample.
  • Minor age-specific differences in physical literacy were noted in some age brackets, but not consistently across most ages.

Conclusions:

  • The study indicates no widespread deficits in physical literacy among children with CHD.
  • Potential for subtle, age-specific variations in physical literacy warrants further investigation.
  • Longitudinal studies are recommended to track individual physical literacy development in children with CHD over time.

Related Concept Videos

Health Literacy01:21

Health Literacy

Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative programs,...
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...